Skip to content
Screener

Arrowhead Research ARWR Deferred Revenue

Deferred Revenue at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$73.84M-2.7%
ALN
Alnylam PharmaceuticalsALNY
$4.01M-73.4%
Assembly Biosciences logo
Assembly BiosciencesASMB
$29.08M-28.8%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$304K-99.6%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$6.12M-65.1%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$48K-96.3%

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$12.28B+445%
Enterprise value$12.2B+446%
P/S19.7×+15.8×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Reported directly by Arrowhead Research in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.

The source filing: Arrowhead Research’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0000879407-26-000047
Line itemMarch 31, 2026September 30, 2025
Accrued expenses76,58590,419
Accrued payroll and benefits20,36626,895
Lease liabilities7,7747,289
Deferred revenue108,5432,399
Credit facility40,00040,000
Other liabilities11,20510,811
Total current liabilities295,220195,487
Long-term liabilities:

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Arrowhead Research's deferred revenue?
Arrowhead Research (ARWR) reported deferred revenue of $108.54M in Q1 2026.
How has Arrowhead Research's deferred revenue changed year-over-year?
Arrowhead Research's deferred revenue increased by 150.9% year-over-year, from $43.27M to $108.54M.
What is the long-term trend for Arrowhead Research's deferred revenue?
Over 4 years (2021 to 2025), Arrowhead Research's deferred revenue has grown at a -61.7% compound annual growth rate (CAGR), from $111.06M to $2.4M.
What does deferred revenue mean?
Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.

Ask your AI about Arrowhead Research's deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude